Last reviewed · How we verify
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER — Competitive Intelligence Brief
marketed
Carbonic anhydrase 4
Other
Live · refreshed every 30 min
Target snapshot
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER (SODIUM PHOSPHATE, MONOBASIC ANHYDROUS) — OTSUKA ICU MEDCL.
Comparator set (4 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER TARGET | SODIUM PHOSPHATE, MONOBASIC ANHYDROUS | OTSUKA ICU MEDCL | marketed | Carbonic anhydrase 4 | ||
| Acid Reflux Relief | Sodium Phosphate, Dibasic, Heptahydrate | Pfizer | marketed | Non-Standardized Plant Allergenic Extract [EPC] | Carbonic anhydrase 4 | 1983-01-01 |
| Potassium Iodide | POTASSIUM IODIDE | Roxane | marketed | Carbonic anhydrase 4 | 1979-01-01 | |
| Micro-K 10 | POTASSIUM CHLORIDE | Nesher Pharms | marketed | potassium chloride | Carbonic anhydrase 4 | 1965-01-01 |
| potassium bromide | potassium bromide | marketed | Carbonic anhydrase 4 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Acid Reflux Relief · 7687075 · US
- — Micro-K 10 · 12539314 · Formulation · US
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER CI watch — RSS
- IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER CI watch — Atom
- IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER CI watch — JSON
- IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER alone — RSS
Cite this brief
Drug Landscape (2026). IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-phosphate-monobasic-anhydrous. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing